Table 7

Frequency of low and high level gains for all the oncogenes analyzed by fluorescence in situ hybridization in medulloblastoma samples

Fluorescence in situ hybridization probeNo. of tumors analyzedNo. of low level gainsNo. of high level gains
Cyclin D1 1808 (4.4%)0
MYC 18014 (7.8%)12 (6.7%)
NRAS 1609 (5.6%)0
STK15 10434 (32.7%)0